Israeli research team gets a step closer to developing a Covid-19 vaccine

The Israel Institute for Biological Research has completed the development phase of Covid-19 antibody

As researchers and medical labs are stepping up their efforts to find a cure for Covid-19, the Isreal Defence Ministry said in a statement that the Israel Institute for Biological Research (IIBR) has completed the development phase of coronavirus antibody or passive vaccine, reports The Jerusalem Post.

The Israeli defence minister was briefed by the research team, who told that this antibody attacks the virus and neutralises it in the body. The institute is now preparing to get a patent for the antibody and contract for its commercial development. The defence ministry of Israel will coordinate this with the IIBR.